TY - JOUR
T1 - Glucose attenuates the effect of combined muscarinic-nicotinic receptor blockade on spontaneous alternation
AU - Ragozzino, Michael E.
AU - Arankowsky-Sandoval, Gloria
AU - Gold, Paul E.
N1 - Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 1994/4/11
Y1 - 1994/4/11
N2 - Glucose administration reverses the effects of both muscarinic and nicotinic cholinergic receptor antagonists on memory and other measures. In experiment 1, we found that glucose attenuated impairments on spontaneous alternation after muscarinic (scopolamine, 0.5 mg/kg) or nicotonic (mecamylamine, 5.0 mg/kg) receptor blockade. In experiment 2, we examined whether glucose could reverse the spontaneous alternation impairments produced by combined muscarinic-nicotinic receptor blockade. Scopolamine (0.1 mg/kg) and mecamylamine (2.5 mg/kg) when administered separately did not modify alternation performance, but when coadministered they decreased spontaneous alternation scores. This decrease was attenuated by glucose at 100, 300, 500 and 3000 mg/kg. These findings suggest that glucose may attenuate the behavioral impairment by enhancing cholinergic activity and/or other neurotransmitter systems.
AB - Glucose administration reverses the effects of both muscarinic and nicotinic cholinergic receptor antagonists on memory and other measures. In experiment 1, we found that glucose attenuated impairments on spontaneous alternation after muscarinic (scopolamine, 0.5 mg/kg) or nicotonic (mecamylamine, 5.0 mg/kg) receptor blockade. In experiment 2, we examined whether glucose could reverse the spontaneous alternation impairments produced by combined muscarinic-nicotinic receptor blockade. Scopolamine (0.1 mg/kg) and mecamylamine (2.5 mg/kg) when administered separately did not modify alternation performance, but when coadministered they decreased spontaneous alternation scores. This decrease was attenuated by glucose at 100, 300, 500 and 3000 mg/kg. These findings suggest that glucose may attenuate the behavioral impairment by enhancing cholinergic activity and/or other neurotransmitter systems.
KW - Glucose
KW - Mecamylamine
KW - Memory
KW - Scopolamine
KW - Spontaneous alternaion
UR - http://www.scopus.com/inward/record.url?scp=0028216888&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028216888&partnerID=8YFLogxK
U2 - 10.1016/0014-2999(94)90612-2
DO - 10.1016/0014-2999(94)90612-2
M3 - Article
C2 - 8026561
AN - SCOPUS:0028216888
SN - 0014-2999
VL - 256
SP - 31
EP - 36
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 1
ER -